News and developments
Discover all the information about the research, development and marketing of immunotherapy treatments and natural food supplements for a healthier life.
15/01/2026
Probelte Pharma SL was awarded a grant from the Murcia Regional Development Agency’s grant programme to encourage SMEs in the region to procure innovation and competitiveness services, co-funded by the European Regional Development Fund. File: 2024.08.hino.000112
The aim of this project was to promote a more efficient business environment, helping to deliver the benefits of tax credits to support business innovation
01/12/2025
Probelte Pharma published the protocol for the PROACAROS phase III Beltavac® clinical trial in the TRIALS journal
Murcia, Spain — May 2025 Probelte Pharma has announced that the full protocol for the PROACAROS phase III clinical trial, designed to evaluate the efficacy and safety of Beltavac® subcutaneous…
